Hadlima (adalimumab or adalimumab-bwwd) is used to treat many different autoimmune conditions, including some types of arthritis, Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis. It's injected under the skin and comes as both prefilled syringes and an autoinjector. This medication is a biosimilar to Humira (adalimumab). And it's expected to be available in the United States on or after July 2023.
Hadlima (adalimumab) is a biologic disease-modifying antirheumatic drug (DMARD). It works by blocking tumor necrosis factor (TNF), a protein in your body that plays a role in inflammation. By blocking TNF, Hadlima (adalimumab) lowers inflammation to relieve symptoms in different parts of your body.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
Body aches or pain
ear congestion
hoarseness
lightheadedness
loss of voice
lower back or side pain
muscle aches and pains
pain or tenderness around the eyes or cheekbones
rapid and sometimes shallow breathing
shivering
stomach fullness
sunken eyes
thirst
trouble sleeping
warmth on the skin
wrinkled skin
Less common
Abnormal vaginal bleeding or discharge
agitation
arm, back, or jaw pain
black, tarry stools
bleeding from the gums or nose
blindness
bloating or swelling of the face, arms, hands, lower legs, or feet
blood in the stool or change in bowel habits
bloody or cloudy urine
blurred vision
broken bones
change in size, shape, or color of an existing mole
change in skin color
chest pain, tightness, or heaviness
chills
clear or bloody discharge from the nipple
cold hands and feet
confusion
coughing or spitting up blood
decreased urination
decreased vision
difficulty with breathing
difficulty, burning, or painful urination
dimpling of the breast skin
dizziness
drowsiness
fainting
fast, slow, or irregular heartbeat
forgetfulness
frequent urge to urinate
general feeling of illness
headache
increased thirst
inverted nipple
irregular breathing
irregular pulse
irritability
light colored stools
loss of appetite
lump in the breast or under your arm
lump or swelling in the stomach
mole that leaks fluid or bleeds
muscle cramps or spasms
new mole
night sweats
no blood pressure or pulse
noisy breathing
numbness or tingling in your arms, legs, or face
pain, redness, or swelling in the arms or legs without any injury present
pale skin
persistent non-healing sore on your skin
pink growth
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
raised, firm, or bright red patch
redness or swelling of the breast
seeing or hearing things that are not there
seizures
sharp back pain just below your ribs
shiny bump on your skin
slurred speech or problems with swallowing
sore on the skin of the breast that does not heal
sores, ulcers, or white spots on the lips or mouth
spitting up blood
stiff neck
stomach pain
stopping of the heart
sudden high fever or low grade fever for months
sweating
swelling of the face, fingers, feet, or lower legs
swollen glands
swollen neck veins
tiredness
trouble breathing
trouble thinking
unconsciousness
unexplained bruising or bleeding
unpleasant breath odor
unusual tiredness or weakness
unusual weight gain or loss
visual disturbances
vomiting
vomiting of blood or material that looks like coffee grounds
yellow skin or eyes
Incidence not known
Blistering, peeling, or loosening of the skin
inability to move the arms and legs
joint or muscle pain
pinpoint red spots on the skin
red skin lesions, often with a purple center
red, irritated eyes
red, scaling, or crusted skin
sudden numbness and weakness in the arms and legs
unusual bleeding or bruising
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Bladder pain
bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
pounding in the ears
Less common
Abnormal healing
decrease in height
difficulty with moving
difficulty with walking
indigestion
loss of hearing
loss of strength or energy
menstrual changes
muscle or joint stiffness, tightness, or rigidity
muscle pain or weakness
pain in the back, ribs, arms, or legs
shakiness in the legs, arms, hands, and feet
swelling or redness in the joints
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Although Hadlima (adalimumab) was already approved by the FDA in 2019, it's expected to be available in the United States on or after July 2023.
Hadlima (adalimumab) is a biosimilar to Humira (adalimumab). This means it's kind of like a generic to Hadlima (adalimumab), but not exactly. Hadlima (adalimumab) has a similar structure and works to treat conditions in the same way as Humira (adalimumab) does. But Hadlima (adalimumab) isn't FDA approved to treat all age groups within a condition that Humira (adalimumab) is. For example, Humira (adalimumab) is FDA approved to treat uveitis (inflammation in the middle layer of the eye) in children and adults, while Hadlima (adalimumab) is approved for use in adults only.
While Hadlima (adalimumab) works similarly to other Humira biosimilars, there are a few differences between them. Hadlima (adalimumab) has been FDA approved for two different strengths (50 mg/mL and 100 mg/mL), whereas other Humira biosimilars are currently only available in the 50 mg/mL strength. And unlike some of the other biosimilars, it also comes as an autoinjector, which might be easier to use than the prefilled syringes. In addition, injections with the higher strength of Hadlima (adalimumab) might be less painful because it's made without citrate, an ingredient that can cause more pain with the injection.
Hadlima (adalimumab) should be injected in the fatty area under your skin. You can inject it either on your lower stomach (at least 2 inches away from your belly button) or on the front of your thighs. To allow your skin to heal, make sure to rotate your injection sites each time. And avoid injecting the medication into skin that's red, bruised, or broken.
Hadlima (adalimumab) works best if you take it consistently. But if you accidentally forget your dose, inject a dose as soon as possible. Then, inject your next dose at your regularly scheduled time. If you have questions about when you should inject Hadlima (adalimumab), ask your provider or pharmacist.
Hadlima (adalimumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Hadlima (adalimumab) can raise your risk of serious or life-threatening infections. Your risk might be higher if you're 65 years or older, taking other medications that can weaken the immune system (e.g., methotrexate, Orencia (abatacept), Kineret (anakinra), corticosteroids), and or have other health conditions. Make sure to discuss your medical history with your provider before starting Hadlima (adalimumab), especially if you've ever had tuberculosis or hepatitis B. They'll review your risk before starting the medication. If you get an infection while taking Hadlima (adalimumab), you might have to stop the medication in order to give your immune system a chance to fight the infection.
In clinical trials, there was a greater number of people who developed cancer while taking a medication similar to Hadlima (adalimumab) when compared to people not taking that medication. Cancers like lymphoma, leukemia, and skin cancers were the most commonly reported types in that study. Your provider will evaluate your risk before starting Hadlima (adalimumab) and monitor you while you're taking the medication. Speak to your provider if you have any concerns.
Rarely, Hadlima (adalimumab) can cause severe allergic reactions. Some reactions may be life-threatening, like anaphylaxis (closing of the throat). If you experience rash, itching, trouble breathing, or swelling in your face, lips, tongue, or throat, get medical help right away.
Hadlima (adalimumab) can rarely cause you to develop nervous system problems, such as multiple sclerosis (MS) and Guillain-Barré syndrome. Let your provider know if you currently have a nervous system condition. They'll want to monitor you closely while you're taking Hadlima (adalimumab), since it can make these problems worse. If you experience numbness or tingling, weakness in your arms or legs, vision problems, or dizziness, call your provider.
Some people taking Hadlima (adalimumab) have experienced low blood cells. This can lower your body's ability to fight infections and raise your risk for bleeding. Contact your provider if you develop a fever that doesn't go away, easy bruising, pale skin, or bleeding.
People taking medications like Hadlima (adalimumab) have had new or worsening cases of heart failure. Tell your provider if you currently have heart failure. They'll help you decide if Hadlima (adalimumab) is right for you. Get medical help right away if you start to have shortness of breath, swelling in the legs, ankles, or feet, irregular heartbeat, or tiredness or weakness, as these can be signs of heart failure.
Hadlima (adalimumab) can rarely cause a condition called lupus-like syndrome. If you experience easy bruising or bleeding, a rash, or feel unusually tired, call your provider to let them know.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 2 autoinjectors of 40mg/0.8ml | 1 carton | $1,002.73 | $1,002.73 |
| 2 syringes of 40mg/0.8ml | 1 carton | $1,002.73 | $1,002.73 |
| 2 autoinjectors of 40mg/0.4ml | 1 carton | $1,002.73 | $1,002.73 |
| 2 syringes of 40mg/0.4ml | 1 carton | $1,002.73 | $1,002.73 |
Adults
Children
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.